Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma NCT05737199 Conditions Ovarian Squamous Cell Carcinoma Locations Niigata University Medical & Dental Hosptal — Niigata, Japan View Trial Details
